Pyxis Oncology Inc

General ticker "PYXS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $105.4M

Pyxis Oncology Inc does not follow the US Stock Market performance with the rate: -3.9%.

Estimated limits based on current volatility of 2.1%: low 1.54$, high 1.69$

Factors to consider:

  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.10$, 2.98$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.30$, 3.34$]

Financial Metrics affecting the PYXS estimates:

  • Negative: Non-GAAP EPS, $ of -1.84 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -50.84 <= 2.35
  • Negative: negative Net income
  • Positive: Inventory ratio change, % of -200 <= -1.03
  • Positive: -3.48 < Investing cash flow per share, $ of -2.63

Similar symbols

Short-term PYXS quotes

Long-term PYXS plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $69.72MM $123.48MM $82.20MM
Operating Income $-69.72MM $-123.48MM $-82.20MM
Non-Operating Income $-6.26MM $2.76MM $8.41MM
R&D Expense $51.05MM $86.13MM $49.59MM
Income(Loss) $-75.97MM $-120.72MM $-73.79MM
Profit(Loss) $-75.97MM $-120.72MM $-73.79MM
Stockholders Equity $261.31MM $160.82MM $125.70MM
Inventory $0.00MM $0.87MM $0.00MM
Assets $280.02MM $211.38MM $173.73MM
Operating Cash Flow $-35.33MM $-89.33MM $-70.71MM
Capital expenditure $0.54MM $6.40MM $6.73MM
Investing Cash Flow $-0.59MM $-6.40MM $-104.85MM
Financing Cash Flow $304.04MM $0.18MM $5.93MM
Earnings Per Share* $-2.53 $-3.57 $-1.85

* EPS are Split Adjusted, recent splits may be reflected with a delay.